Insights on Life Sciences
Article
Medtech needs more than a market rotation to win back investors
-
With industry performance plateauing, medtech leaders must earn back investor trust with fresh strategies and better execution.
Article
AI drug discovery: Focusing on what matters most
-
AI is accelerating drug discovery, but investment has concentrated in molecule design—the stage with the best data and...
Interview
Putting innovation—and patients—in focus: A conversation with Astellas Pharma CEO Naoki Okamura
-
The Tokyo-based biopharmaceutical company is accelerating its pipeline by innovating at the intersection of biology, modality,...
Article
From linear gates to learning loops: Rewiring biopharma R&D with AI
-
An AI-powered R&D model built on connected decision loops—replacing the current sequential, fragmented workflow—can...
Article
The emerging epicenter: Asia’s role in biopharma’s future
-
Asia is now the epicenter of global biopharmaceutical progress—outpacing the United States and Europe in pipeline growth,...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.